Loading...

Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains

Published
09 Feb 25
Updated
18 Oct 25
AnalystConsensusTarget's Fair Value
NZ$32.64
12.1% undervalued intrinsic discount
18 Oct
NZ$28.70
Loading
1Y
-21.3%
7D
-3.0%

Author's Valuation

NZ$32.6412.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on18 Oct 25
Fair value Decreased 12%

Analysts have revised their price target for EBOS Group downward from $36.96 to $32.64. This adjustment is due to lowered revenue growth expectations, while profit margins and discount rates remain stable.

Shared on17 Sep 25
Fair value Decreased 2.62%

EBOS Group’s consensus price target has been revised downward as a result of an increased future P/E ratio without a meaningful improvement in revenue growth expectations, reducing the fair value estimate from NZ$37.96 to NZ$36.96. What's in the News EBOS Group announced a supplementary dividend distribution of NZD 0.02713235 for the six months ended June 30, 2026; record date is 5 September, ex-date is 4 September, and payment date is 24 September.

Shared on28 Aug 25
Fair value Decreased 3.96%

A slight rise in EBOS Group’s future P/E ratio, with virtually unchanged revenue growth forecasts, suggests increased valuation multiples underpin a marginal decrease in the consensus analyst price target from NZ$39.53 to NZ$38.95. Valuation Changes Summary of Valuation Changes for EBOS Group The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from NZ$39.53 to NZ$38.95.

Shared on01 May 25
Fair value Decreased 3.41%

Shared on23 Apr 25
Fair value Increased 1.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.72%

AnalystConsensusTarget has increased revenue growth from 3.6% to 4.1%.

Shared on09 Apr 25
Fair value Increased 0.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 1.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 1.94%

AnalystConsensusTarget has decreased revenue growth from 4.1% to 3.3%.

Shared on12 Mar 25
Fair value Decreased 0.73%